Independent Franchise Partners LLP Bristol Myers Squibb CO Transaction History

Independent Franchise Partners LLP

$9.6 Billion
Q2 2024

A detailed history of Independent Franchise Partners LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Independent Franchise Partners LLP holds 14,600,621 shares of BMY stock, worth $777 Million. This represents 6.32% of its overall portfolio holdings.

Number of Shares

14,600,621

Previous 14,044,326 3.96%

Holding current value

$777 Million

Previous $762 Million 20.39%

% of portfolio

6.32%

Previous 7.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $22.4 Million - $29.5 Million	556,295 Added 3.96%	14,600,621 $606 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $997,312 - $1.13 Million	-20,786 Reduced 0.15%	14,044,326 $762 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $33.2 Million - $39.6 Million	-684,567 Reduced 4.64%	14,065,112 $722 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $128 Million - $143 Million	2,210,239 Added 17.63%	14,749,679 $856 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $48.1 Million - $53.4 Million	755,208 Added 6.41%	12,539,440 $802 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $3.04 Million - $3.45 Million	-46,252 Reduced 0.39%	11,784,232 $817 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $14.7 Million - $17.4 Million	-214,010 Reduced 1.78%	11,830,484 $851 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $44,520 - $26.3 Million	-342,464 Reduced 2.76%	12,044,494 $856 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $193 Million - $212 Million	-2,656,135 Reduced 17.66%	12,386,958 $954 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $47 Million - $56.4 Million	-764,662 Reduced 4.84%	15,043,093 $1.1 Billion
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $171 Million - $200 Million	3,192,337 Added 25.31%	15,807,755 $986 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $61.3 Million - $71.8 Million	-1,036,139 Reduced 7.59%	12,615,418 $746 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $203 Million - $221 Million	3,282,292 Added 31.65%	13,651,557 $912 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $37.6 Million - $42.3 Million	633,218 Added 6.5%	10,369,265 $655 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $7.69 Million - $8.71 Million	133,098 Added 1.39%	9,736,047 $604 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $71.7 Million - $79.4 Million	-1,248,129 Reduced 11.5%	9,602,949 $579 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $107 Million - $125 Million	1,948,073 Added 21.88%	10,851,078 $638 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $55.4 Million - $80.5 Million	1,193,606 Added 15.48%	8,903,005 $496 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $8.25 Million - $10.8 Million	-167,601 Reduced 2.13%	7,709,399 $495 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $337 Million - $399 Million	7,877,000 New	7,877,000 $399 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Franchise Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Independent Franchise Partners LLP with notifications on news.

Account

Independent Franchise Partners LLP Bristol Myers Squibb CO Transaction History